AMERICAN SHARED HOSPITAL SERVICES Interest Income Interest Earning Asset
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Interest Income Interest Earning Asset of $29.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeInterestEarningAsset · last filed 2026-08-13
- AMERICAN SHARED HOSPITAL SERVICES interest income interest earning asset for the quarter ending 2026-06-30 was $29.00K, a 39.58% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES interest income interest earning asset for the quarter ending 2026-03-31 was $53.00K, a 28.38% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES interest income interest earning asset for the quarter ending 2025-12-31 was $29.00K, a 67.78% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES interest income interest earning asset for the quarter ending 2025-09-30 was $34.00K, a 46.03% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES interest income interest earning asset for fiscal 2025 was $186.00K, a 45.61% decline from fiscal 2024.
- AMERICAN SHARED HOSPITAL SERVICES interest income interest earning asset for fiscal 2024 was $342.00K, a 25.33% decline from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES interest income interest earning asset for fiscal 2023 was $458.00K, a 344.66% increase from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES interest income interest earning asset for fiscal 2022 was $103.00K.
| Period end | Interest Income Interest Earning Asset 3 month | Interest Income Interest Earning Asset 6 month | Interest Income Interest Earning Asset 9 month | Interest Income Interest Earning Asset 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-08-13 | $82.00K 10-Q · filed 2026-08-13 | $111.00K derived: sum of 3 quarters · filed 2026-08-13 | $145.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $53.00K 10-Q · filed 2026-05-14 | $82.00K derived: sum of 2 quarters · filed 2026-05-14 | $116.00K derived: sum of 3 quarters · filed 2026-05-14 | $164.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $29.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $63.00K derived: sum of 2 quarters · filed 2026-03-31 | $111.00K derived: sum of 3 quarters · filed 2026-08-13 | $186.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $34.00K 10-Q/A · filed 2026-01-16 | $82.00K derived: sum of 2 quarters · filed 2026-08-13 | $157.00K 10-Q/A · filed 2026-01-16 | $246.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $48.00K 10-Q · filed 2026-08-13 | $122.00K 10-Q · filed 2026-08-13 | $212.00K derived: sum of 3 quarters · filed 2026-08-13 | $275.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $74.00K 10-Q · filed 2026-05-14 | $164.00K derived: sum of 2 quarters · filed 2026-05-14 | $227.00K derived: sum of 3 quarters · filed 2026-05-14 | $304.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $90.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-31 | $153.00K derived: sum of 2 quarters · filed 2026-03-31 | $230.00K derived: sum of 3 quarters · filed 2026-03-31 | $342.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $63.00K 10-Q/A · filed 2026-01-16 | $140.00K derived: sum of 2 quarters · filed 2026-01-16 | $252.00K 10-Q/A · filed 2026-01-16 | $363.00K derived: sum of 4 quarters · filed 2026-01-16 |
| 2024-06-30 | $77.00K 10-Q · filed 2025-08-13 | $189.00K 10-Q · filed 2025-08-13 | $300.00K derived: sum of 3 quarters · filed 2025-08-13 | $449.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $111.00K 10-Q · filed 2025-05-15 | $223.00K derived: sum of 2 quarters · filed 2025-05-15 | $372.00K derived: sum of 3 quarters · filed 2025-05-15 | $482.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $261.00K derived: sum of 2 quarters · filed 2025-04-04 | $371.00K derived: sum of 3 quarters · filed 2025-04-04 | $458.00K 10-K · filed 2025-04-04 |
| 2023-09-30 | $149.00K 10-Q · filed 2024-11-14 | $259.00K derived: sum of 2 quarters · filed 2024-11-14 | $346.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $110.00K 10-Q · filed 2024-08-14 | $197.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $87.00K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $103.00K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |